Evaluating single-dose methotrexate alone versus methotrexate with letrozole for treating ectopic pregnancy: a...

Area of Science:

• Reproductive endocrinology and infertility
• Pharmacological interventions in obstetrics
• Gynecological oncology

Background:

• Ectopic pregnancy (EP) affects 1-2% of pregnancies.
• Methotrexate (MTX) is a common treatment for EP but has limitations and side effects.
• Letrozole, an aromatase inhibitor, has been explored as an adjunct therapy.

Purpose of the Study:

• To investigate the efficacy of combining letrozole with methotrexate for managing ectopic pregnancy.
• To compare the treatment outcomes of methotrexate alone versus methotrexate plus letrozole.

Main Methods:

• A randomized study involving 60 patients with ectopic pregnancy.
• Patients were divided into two groups: MTX alone and MTX + letrozole.
• Primary outcome: change in serum β-hCG levels; Secondary outcomes: surgical intervention rates and side effects.

Main Results:

• Both treatment groups exhibited similar success rates and no significant difference in the need for surgical intervention.
• Serum β-hCG levels decreased more rapidly in the MTX + letrozole group, though not statistically significant.
• The combination therapy demonstrated comparable efficacy to single-dose MTX for ectopic pregnancy.

Conclusions:

• Letrozole may potentially enhance MTX therapy by accelerating β-hCG reduction.
• Further research with larger cohorts and extended follow-up is warranted to validate these findings.